Turku Bioscience News

MicroRNAs may reveal type 1 diabetes
June 26, 2023

SAVE THE DATE: BioCity PhD Mini-Symposium is coming!
May 26, 2023

Turku Bioscience funding news May 2023
May 23, 2023

DDCB symposium on May 4th 2023
May 4, 2023
August 17, 2023
Finnish and Japanese immunologists will get together on the 29th-30th of August, 2023 to share and discuss their recent results. The Finnish-Japanese Immunology Symposium "Emerging concepts in immunology - From basic mechanisms to treating immune Read more
July 13, 2023
Researchers have found a possible explanation as to why higher breast density and older age increase the risk of breast cancer. In an innovative study, Read more
June 26, 2023
MicroRNAs are short RNA strands, of which more than 2,300 have been identified in humans. Their abnormal expression contributes to the development of many diseases, Read more
June 6, 2023
Academia Europaea is a European, non-governmental association acting as an Academy which covers all disciplines and invites distinguished scientists to become members based on peer Read more
May 31, 2023
Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the Read more
May 26, 2023
A team of Doctoral Researchers are delighted to announce the BioCity PhD Mini-Symposium planned on the afternoon before the main symposium, i.e., on Wednesday 23rd August, 2023. This will Read more
May 25, 2023
Mikael Knip of the University of Helsinki is conferred as a Turku University honorary doctor in medicine for his merits in the research of type Read more
May 23, 2023
We are delighted to share the following funding news with everyone. Warmest congratulations to those who got funded. BioCity Turku Collaborative Research Funding Call Results All funded projects are listed here: https://biocityturku.fi/research-programs/
May 23, 2023
The EURAS consortium received Horizon funding to develop new treatments for rare neurodevelopmental disorders of the Ras pathway.
May 16, 2023
Our lab has now opened a position to join us on the EURAS consortium project. The deadline for applications is now extended until 1 August 2023. The description and application links can be found Read more
May 12, 2023
Rare neurodevelopmental disorders of the Ras pathway continue to evade effective treatment. The EURAS consortium has been awarded ~8 million euros from the Health Cluster of the Horizon Europe Research and Innovation Programme to develop Read more
May 4, 2023
How could your research benefit from the chemical biology and drug discovery tools and infrastructure available in Finland? Find out on 4th May 2023 at the symposium held by the Drug Discovery and Chemical Biology Read more